PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination |
Jin, Min
(Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine)
Park, Seon-Joo (Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine) Kim, Seok Won (Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine) Kim, Hye Rim (Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine) Hyun, Jin Won (Department of Biochemistry, School of Medicine, Jeju National University) Lee, Jung-Hee (Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine) |
1 | Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W. and Vogelstein, B. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860. DOI |
2 | Pan, Y. and Chen, J. (2003) MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23, 5113-5121. DOI |
3 | Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D. and Levine, A. J. (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 90, 11623-11627. DOI |
4 | Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305. DOI |
5 | Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., Cordon-Cardo, C. and DePinho, R. A. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92, 713-723. DOI |
6 | Porte, S., Valencia, E., Yakovtseva, E. A., Borras, E., Shafqat, N., Debreczeny, J. E., Pike, A. C., Oppermann, U., Farres, J., Fita, I. and Pares, X. (2009) Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3. J. Biol. Chem. 284, 17194-17205. DOI |
7 | Poyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z. Q., Pavletich, N. and Prives, C. (2007) The Mdm2 RING domain Cterminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J. 26, 90-101. DOI |
8 | Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J. K., Zhong, S., Campargue, I., Naumovski, L., Crook, T. and Lu, X. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8, 781-794. DOI |
9 | Asher, G., Lotem, J., Cohen, B., Sachs, L. and Shaul, Y. (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U.S.A. 98, 1188-1193. DOI |
10 | Ashcroft, M., Taya, Y. and Vousden, K. H. (2000) Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20, 3224-3233. DOI |
11 | Asher, G., Lotem, J., Kama, R., Sachs, L. and Shaul, Y. (2002a) NQO1 stabilizes p53 through a distinct pathway. Proc. Natl. Acad. Sci. U.S.A. 99, 3099-3104. DOI |
12 | Asher, G., Lotem, J., Sachs, L., Kahana, C. and Shaul, Y. (2002b) Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. U.S.A. 99, 13125-13130. DOI |
13 | Uldrijan, S., Pannekoek, W. J. and Vousden, K. H. (2007) An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. EMBO J. 26, 102-112. DOI |
14 | Shieh, S. Y., Ikeda, M., Taya, Y. and Prives, C. (1997) DNA damageinduced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334. DOI |
15 | Sui, G., Affar E. B., Shi, Y., Brignone, C., Wall, N. R., Yin, P., Donohoe, M., Luke, M. P., Calvo, D., Grossman, S. R. and Shi, Y. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117, 859-872. DOI |
16 | Tang, J., Qu, L. K., Zhang, J., Wang, W., Michaelson, J. S., Degenhardt, Y. Y., El-Deiry, W. S. and Yang, X. (2006) Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8, 855-862. DOI |
17 | Unger, T., Juven-Gershon, T., Moallem, E., Berger, M., Vogt Sionov, R., Lozano, G., Oren, M. and Haupt, Y. (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805-1814. DOI |
18 | Zhang, Z. and Zhang, R. (2008) Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 27, 852-864. DOI |
19 | Wang, H., Luo, K., Tan, L. Z., Ren, B. G., Gu, L. Q., Michalopoulos, G., Luo, J. H. and Yu, Y. P. (2012) p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3. J. Biol. Chem. 287, 16890-16902. DOI |
20 | Zhang, X., Wang, W., Wang, H., Wang, M. H., Xu, W. and Zhang, R. (2013) Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene 32, 2782-2791. DOI |
21 | Zhou, X., Hao, Q., Liao, J., Zhang, Q. and Lu, H. (2013) Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 32, 388-396. DOI |
22 | de Graaf, P., Little, N. A., Ramos, Y. F., Meulmeester, E., Letteboer, S. J. and Jochemsen, A. G. (2003) Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2. J. Biol. Chem. 278, 38315-38324. DOI |
23 | Barak, Y., Juven, T., Haffner, R. and Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468. |
24 | Burger, A. M. and Seth, A. K. (2004) The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur. J. Cancer 40, 2217-2229. DOI |
25 | Contente, A., Dittmer, A., Koch, M. C., Roth, J. and Dobbelstein, M. (2002) A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat. Genet. 30, 315-320. DOI |
26 | Fernald, K. and Kurokawa, M. (2013) Evading apoptosis in cancer. Trends Cell Biol. 23, 620-633. DOI |
27 | Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M., Doumont, G., Bellefroid, E. and Marine, J. C. (2006) Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 3232-3237. DOI |
28 | Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299. DOI |
29 | Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E. and Yao, T. P. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236-6245. DOI |
30 | Ito, A., Lai, C. H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E. and Yao, T. P. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20, 1331-1340. DOI |
31 | Kang, M. Y., Kim, H. B., Piao, C., Lee, K. H., Hyun, J. W., Chang, I. Y. and You, H. J. (2013) The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ. 20, 117-129. DOI |
32 | Kubbutat, M. H., Jones, S. N. and Vousden, K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303. DOI |
33 | Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K. K. and Yuan, Z. M. (2003) DNA damage-induced MDMX degradation is mediated by MDM2. J. Biol. Chem. 278, 45946-45953. DOI |
34 | Kobet, E., Zeng, X., Zhu, Y., Keller, D. and Lu, H. (2000) MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc. Natl. Acad. Sci. U.S.A. 97, 12547-12552. DOI |
35 | Kotsinas, A., Aggarwal, V., Tan, E. J., Levy, B. and Gorgoulis, V. G. (2012) PIG3: a novel link between oxidative stress and DNA damage response in cancer. Cancer Lett. 327, 97-102. DOI |
36 | Lane, D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16. DOI |
37 | Lee, J. H., Kang, Y., Khare, V., Jin, Z. Y., Kang, M. Y., Yoon, Y., Hyun, J. W., Chung, M. H., Cho, S. I., Jun, J. Y., Chang, I. Y. and You, H. J. (2010) The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene 29, 1431-1450. DOI |
38 | Li, B., Shang, Z. F., Yin, J. J., Xu, Q. Z., Liu, X. D., Wang, Y., Zhang, S. M., Guan, H. and Zhou, P. K. (2013) PIG3 functions in DNA damage response through regulating DNA-PKcs homeostasis. Int. J. Biol. Sci. 9, 425-434. DOI |
39 | Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331. DOI |
40 | Levine, A. J. and Oren, M. (2009) The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9, 749-758. DOI |
41 | Momand, J., Zambetti, G. P., Olson, D. C., George, D. and Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245. DOI |